SPONSOR
The First Affiliated Hospital of Zhengzhou University
Total Trials
7
Recruiting
7
Phases
Phase 4, Phase 1, Phase 2
Conditions studied: Brain GliomaGastric CancerCTHCCNon-Small Cell Lung CancerChemotherapyPD1 AntibodyGlutathioneEsophageal Squamous Cell CarcinomaGlioma
The First Affiliated Hospital of Zhengzhou University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Brain Glioma, Gastric Cancer, CT, HCC.
The trial portfolio spans Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital of Zhengzhou University
How many clinical trials has The First Affiliated Hospital of Zhengzhou University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by The First Affiliated Hospital of Zhengzhou University, of which 7 are actively recruiting participants. These trials cover conditions including Brain Glioma, Gastric Cancer, CT. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital of Zhengzhou University research focus on?
The First Affiliated Hospital of Zhengzhou University clinical trials span Brain Glioma, Gastric Cancer, CT, HCC, Non-Small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Affiliated Hospital of Zhengzhou University clinical trial?
To participate in a The First Affiliated Hospital of Zhengzhou University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital of Zhengzhou University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital of Zhengzhou University
NCT06747728
Recruiting
Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
Brain Glioma
NCT06869694
Recruiting
Energy CT in Imaging and Diagnosis of Gastric Cancer
Gastric Cancer
NCT06930573 Phase 4
Recruiting
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk
HCC
NCT06896422 Phase 1
Recruiting
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
Non-Small Cell Lung Cancer
NCT07016724 Phase 2
Recruiting
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
Esophageal Squamous Cell Carcinoma
NCT04215211
Recruiting
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence
Glioma
NCT06557161 Phase 2
Recruiting
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
Acute Lymphoblastic Leukemia, Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology